Neutral dioxovanadium(V) complexes of biomimetic hydrazones ONO donor ligands of bioinorganic and medicinal relevance: Synthesis via air oxidation of bis(acetylaceto-nato)oxovanadium(IV), characterization, biological activity and 3D molecular modeling

Palladium(ii), platinum(ii), and silver(i) complexes with 3-acetylcoumarin benzoylhydrazone Schiff base: Synthesis, characterization, biomolecular interactions, cytotoxic activity, and computational studies

New Pd(ii) (C1), Pt(ii) (C2), and Ag(i) (C3) complexes derived from 3-acetylcoumarin benzoylhydrazone (HL) Schiff base were synthesized and characterized by FTIR, 1H NMR, UV-visible spectroscopies along with elemental analysis (C, H, N), magnetic, molar conductivity measurements, and DFT calculations. The obtained results suggested that the ligand had different behaviors in the complexes: mono-negative tridentate (C1) and neutral tridentate (C2) as an ONO-donor and neutral bidentate (C3) as an ON-donor. Quantum chemistry calculations were performed to validate the stability of the suggested geometries and indicated that all the complexes possess tetra-coordinated metal ions. The binding affinity of all the compounds toward calf thymus (ctDNA), yeast (tRNA), and bovine serum albumin (BSA) was evaluated by absorption/emission spectral titration studies, which revealed the intercalative binding to ctDNA and tRNA and static binding upon complex formation with BSA. Molecular insights into the binding affinity of the characterized complexes were provided through conducting molecular docking analysis. Moreover, the cytotoxic activity (in vitro) of the compounds was screened against human cancerous cell lines and a non-cancerous lung fibroblast (WI38) one using cis-platin as a reference drug. The IC50 and selective index (SI) values indicated the higher cytotoxic activity of all the metal complexes compared to their parent ligand. Among all the compounds, the complex C2 showed the highest activity. These results confirmed the improvement of the anticancer activity of the ligand by incorporating the metal ions. In addition, flow cytometry results showed that complexes C1 and C2 induced cell cycle arrest at S and G1/S, respectively.

Recent developments of metal-based compounds against fungal pathogens

This review provides insight into the rapidly expanding field of metal-based antifungal agents. In recent decades, the antibacterial resistance crisis has caused reflection on many aspects of public health where weaknesses in our medicinal arsenal may potentially be present - including in the treatment of fungal infections, particularly in the immunocompromised and those with underlying health conditions where mortality rates can exceed 50%. Combination of organic moieties with known antifungal properties and metal ions can lead to increased bioavailability, uptake and efficacy. Development of such organometallic drugs may alleviate pressure on existing antifungal medications. Prodigious antimicrobial moieties such as azoles, Schiff bases, thiosemicarbazones and others reported herein lend themselves easily to the coordination of a host of metal ions, which can vastly improve the biocidal activity of the parent ligand, thereby extending the library of antifungal drugs available to medical professionals for treatment of an increasing incidence of fungal infections. Overall, this review shows the impressive but somewhat unexploited potential of metal-based compounds to treat fungal infections.

Preparation, Antimicrobial Activity and Docking Study of Vanadium Mixed Ligand Complexes Containing 4-Amino-5-hydrazinyl-4H-1,2,4-triazole-3-thiol and Aminophenol Derivatives

The synthesis of mixed-ligand complexes is considered an important strategy for developing new metal complexes of enhanced biological activity. This paper presents the synthesis, characterization, in vitro antimicrobial assessment, and theoretical molecular docking evaluation for synthesized oxidovanadium (V) complexes. The proposed structures of the synthesized compounds were proved using elemental and different spectroscopic analysis. The antimicrobial tests showed moderate activity of the compounds against the Gram-positive bacterial strains and the fungal yeast, whereas no activity was observed against the Gram-negative bacterial strains. The performance of density functional theory (DFT) was conducted to study the interaction mode of the targeted compounds with the biological system. Calculating the quantitative structure-activity relationship (QSPR) was performed depending on optimization geometries, frontier molecular orbitals (FMOs), and chemical reactivities for synthesized compounds. The molecular electrostatic potentials (MEPs) that were plotted link the interaction manner of synthesized compounds with the receptor. The molecular docking evaluation revealed that the examined compounds may possess potential antibacterial activity.

Synthesis, Characterization, and In Vivo Anti-Cancer Activity of New Metal Complexes Derived from Isatin-N(4)antipyrinethiosemicarbazone Ligand Against Ehrlich Ascites Carcinoma Cells

The current study aimed to synthesize new metal coordination complexes with potential biomedical applications. Metal complexes were prepared via the reaction of isatin-N(4)anti- pyrinethiosemicarbazone ligand 1 with Cu(II), Ni(II), Co(II), Zn(II), and Fe(III) ions. The obtained metal complexes 2-12 were characterized using elemental, spectral (¹H-NMR, EPR, Mass, IR, UV-Vis) and thermal (TGA) techniques, as well as magnetic moment and molar conductance measurements. In addition, their geometries were studied using EPR and UV-Vis spectroscopy. To evaluate the in vivo anti-cancer activities of these complexes, the ligand 1 and its metal complexes 2, 7 and 9 were tested against solid tumors. The solid tumors were induced by subcutaneous (SC) injection of Ehrlich ascites carcinoma (EAC) cells in mice. The impact of the selected complexes on the reduction of tumor volume was determined. Also, the expression levels of vascular endothelial growth factor (VEGF) and cysteine aspartyl-specific protease-7 (caspase-7) in tumor and liver tissues of mice bearing EAC tumor were determined. Moreover, their effects on alanine transaminase (ALT), aspartate transaminase (AST), albumin, and glucose levels were measured. The results revealed that the tested compounds, especially complex 9, reduced tumor volume, inhibited the expression of VEGF, and induced the expression of caspase-7. Additionally, they restored the levels of ALT, AST, albumin, and glucose close to their normal levels. Taken together, our newly synthesized metal complexes are promising anti-cancer agents against solid tumors induced by EAC cells as supported by the inhibition of VEGF and induction of caspase-7.

Oxidovanadium(v) complexes of aroylhydrazones incorporating heterocycles: synthesis, characterization and study of DNA binding, photo-induced DNA cleavage and cytotoxic activities

The interaction of four neutral oxidovanadium(v) complexes with DNA and their cytotoxic activities have been reported.

Synthesis, Structural Characterization, and Electrochemical Studies of New Oxovanadium(V) Complexes Derived from 2-Furanoylhydrazon Derivatives

Five monooxovanadium(V) complexes [VO(L1)(OCH3)(OHCH3)](1), [VO(L2)(OCH3)(OHCH3)](2), [VO(L3)(OCH3)(OHCH3)](3), [VO(L4)(OCH3)(OHCH3)](4), and [VO(L5)(OCH3)(OHCH3)](5)were synthesized and characterized by IR, NMR UV-Vis, and single-crystal structure analysis [H2L1=(E)-N′-((2-hydroxynaphthalen-1-yl)methylene)furan-2-carbohydrazide,H2L2=(E)-N′-(2-hydroxybenzylidene)furan-2-carbohydrazide, H2L3(E)-N′-(5-bromo-2-hydroxybenzylidene)furan-2-carbohydrazide,H2L4=(E)-N′-(2-hydroxy-5-nitrobenzylidene)furan-2-carbohydrazide,H2L5=(E)-N′-(2-hydroxy-5-iodobenzylidene)furan-2-carbohydrazide]. In all1–3structures the vanadium atom has a distorted octahedral coordination with the three meridional donor atoms from the Schiff base dianion (L1–3)2−and one methoxylato group occupying the sites of the equatorial plane. The oxo group and one methanol molecule occupy the apical sites. In the complexes1,2, and3the conformation of 2-furanyl oxygen atom relative to the carbohydrazide oxygen atom iss-anti,s-anti/s-syn, ands-syn at 293 K, respectively. Cyclic voltammetric experiments of the solution species1–5in DMSO revealed a quasi-reversible behavior.

Synthesis and characterization of Mo(VI) complexes derived from ONO donor acylhydrazones

Four new dioxomolybdenum(VI) complexes were prepared using different acylhydrazones. Hydrazones used for complexation were derived from 2-hydroxy-4-methoxybenzaldehyde, 2-hydroxy-4-methoxyacetophenone, benzhydrazide and nicotinoyl hydrazide. The complexes were characterized by various spectroscopic techniques, thermal and elemental analyses. The (1)H NMR and IR spectral data indicate tridentate nature of the ligands through enolization. IR spectra provide information about the dimeric nature of the complexes. The thermal analyses of the complexes showed the presence of lattice water in some of the complexes.

Versatile binding properties of a di-2-pyridyl ketone nicotinoylhydrazone ligand: crystal structure of a Cu(II) complex

Six new copper complexes of di-2-pyridyl ketone nicotinoylhydrazone (HDKN) have been synthesized. The complexes have been characterized by a variety of spectroscopic techniques and the structure of [Cu(DKN)(2)]·H(2)O has been determined by single crystal X-ray diffraction. The compound [Cu(DKN)(2)]·H(2)O crystallized in the monoclinic space group P2(1) and has a distorted octahedral geometry. The IR spectra revealed the presence of variable modes of chelation for the investigated ligand. The EPR spectra of compounds [Cu(2)(DKN)(2)(μ-N(3))(2)] and [Cu(2)(DKN)(2)(μ-NCS)(2)] in polycrystalline state suggest a dimeric structure as they exhibited a half field signal, which indicate the presence of a weak interaction between two Cu(II) ions in these complexes.

Design and characterization of Cu(II) complexes from 2-benzoylpyridine benzhydrazone: crystallographic evidence for coordination versatility

The syntheses and characterization of six copper(II) complexes of 2-benzoylpyridine benzhydrazone in the form of [Cu(BPB)(2)], [Cu(BPB)Cl].H(2)O, [Cu(BPB)Br], [Cu(2)(BPB)(2)](ClO(4))(2).4H(2)O, [Cu(BPB)N(3)].H(2)O, and [Cu(BPB)NCS].H(2)O.CH(3)OH are reported. The analytical methods used for the characterization of complexes include partial elemental analyses, IR, electronic and EPR spectra, conductivity measurements, magnetic susceptibility measurements and single crystal X-ray diffraction. From the crystal structure, it is clear that the hydrazone adopts the E conformation about the azo bond to attach to the metal through the N(py)-N(azo)-O chelating system. In the EPR spectra of complexes in DMF at 77K four hyperfine quartets in the parallel region could be resolved and a half field signal is observed at 1500 G for complex [Cu(2)(BPB)(2)](ClO(4))(2).4H(2)O in polycrystalline state at 298 K which gives evidence for its binuclear nature indicating a weak interaction between the two Cu(II) ions.

Synthesis of Novel Metal Complexes with Isonicotinoyl Hydrazide and their Antibacterial Activity

A new series of Mn(II), Co(II), Ni(II), Cu(II), Fe(III), Zn(II), Cd(II), Zr(IV) and Ag(I) complexes of 1-(2-phenylhydrazone propane-2-ylidene) isonicotinoylhydrazide (1) have been prepared and characterised. The complexes are non electrolytes and the ESR spectra of the solid complexes [Cu(1)2(OAc)2].3H2O, (3), [CuCl2(1)].0.5H2O, (8), [Mn(1)2(OAc)2].H2O, (5) and [MnCl2(1)2].2H2O, (11) are isotropic, whereas those of [Co(1)2(OAc)2].3H2O, (4) and [Co(1)(NO3)2]. 1.5H2O, (20) are non-axial and axial in type. Antibacterial studies show that the metal complexes exhibit a greater inhibitory effect than (1).

Applications of heteronuclear NMR spectroscopy in biological and medicinal inorganic chemistry

There is a wide range of potential applications of inorganic compounds, and metal coordination complexes in particular, in medicine but progress is hampered by a lack of methods to study their speciation. The biological activity of metal complexes is determined by the metal itself, its oxidation state, the types and number of coordinated ligands and their strength of binding, the geometry of the complex, redox potential and ligand exchange rates. For organic drugs a variety of readily observed spin I = 1/2 nuclei can be used (1H, 13C, 15N, 19F, 31P), but only a few metals fall into this category. Most are quadrupolar nuclei giving rise to broad lines with low detection sensitivity (for biological systems). However we show that, in some cases, heteronuclear NMR studies can provide new insights into the biological and medicinal chemistry of a range of elements and these data will stimulate further advances in this area.